 |
|
Differences in Urodynamic Variables for Vesicoureteral Reflux Depending on the Neurogenic Bladder Type
Je Sang Lee, Bon Il Koo, Myung Jun Shin, Jae Hyeok Chang, Soo-Yeon Kim, Hyun-Yoon Ko
Ann Rehabil Med. 2014;38(3):347-352. Published online 2014 Jun 26 DOI: https://doi.org/10.5535/arm.2014.38.3.347
|
|
Citations to this article as recorded by
 Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
Mohammad Sajjad Rahnama'i, Amin Bagheri, Elham Jahantabi, Hanieh Salehi-Pourmehr, Hadi Mostafaei, Brigitte Schurch, Aida Javan Balegh Marand, Sakineh Hajebrahimi
Asian Journal of Urology.2024; 11(1): 93. CrossRef Long-Term Surveillance and Management of Urological Complications in Chronic Spinal Cord-Injured Patients
Shu-Yu Wu, Jia-Fong Jhang, Hsin-Ho Liu, Jian-Ting Chen, Jian-Ri Li, Bin Chiu, Sung-Lang Chen, Hann-Chorng Kuo
Journal of Clinical Medicine.2022; 11(24): 7307. CrossRef Incidence and predictive factors for developing vesicoureteric reflux in individuals with suprasarcral spinal cord injury: a historical cohort study
Patpiya Sirasaporn, Jittima Saengsuwan
Spinal Cord.2021; 59(7): 753. CrossRef Endoscopic treatment of vesicoureteral reflux with macroplastique in spinal cord injury patients: A comparison of video-urodynamic parameters between treated and failed cases
Vasileios Sakalis, Rachel Oliver, Peter Guy, Melissa Davies
Hellenic Urology.2021; 33(2): 40. CrossRef Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population with presumed healthy bladders
Vasileios I. Sakalis, Rachel Oliver, Peter J. Guy, Melissa C. Davies
The Journal of Spinal Cord Medicine.2019; 42(4): 478. CrossRef Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
Shang-Jun Wu, Yu-Qiong Xu, Zheng-Yan Gao, Zhi-Peng Wang, Feng Zhao, Lin Liu, Sheng Wang
Renal Failure.2019; 41(1): 937. CrossRef Application of data mining techniques to explore predictors of upper urinary tract damage in patients with neurogenic bladder
H. Fang, B. Lu, X. Wang, L. Zheng, K. Sun, W. Cai
Brazilian Journal of Medical and Biological Research.2017;[Epub] CrossRef Neuro-urologische Diagnostik und Therapie bei Funktionsstörungen des unteren Harntrakts nach einer Rückenmarkschädigung
R. Böthig, B. Domurath, A. Kaufmann, J. Bremer, W. Vance, I. Kurze
Der Urologe.2017; 56(6): 785. CrossRef A systematic review and meta-analysis of effectiveness and safety of therapy for overactive bladder using botulinum toxin A at different dosages
Hui-Yun Gu, Ju-Kun Song, Wen-Jun Zhang, Jin Xie, Qi-Sheng Yao, Wen-Jing Zeng, Chao Zhang, Yu-Ming Niu
Oncotarget.2017; 8(52): 90338. CrossRef Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tao Cheng, Wei-bing Shuang, Dong-dong Jia, Min Zhang, Xu-nan Tong, Wei-dong Yang, Xu-ming Jia, Shuo Li, Robert K Hills
PLOS ONE.2016; 11(7): e0159307. CrossRef
|